We estimate that the CEO of GLAUKOS Corp ($GKOS), Thomas W. Burns, received a compensation of $12,034,087 in 2025. This is an increase of 24.96% from an estimated $9,030,345 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 16, 2026. Note that parsing errors may occur.
You can track $GKOS on Quiver Quantitative's $GKOS stock dashboard.
$GKOS Stock Insider Trading Activity
$GKOS Stock insiders have traded $GKOS stock on the open market 29 times in the past 6 months. Of those trades, 0 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $GKOS stock by insiders over the last 6 months:
- THOMAS WILLIAM BURNS (CHAIRMAN & CEO) has made 0 purchases and 2 sales selling 275,000 shares for an estimated $31,625,000.
- JOSEPH E GILLIAM (PRESIDENT & COO) has made 0 purchases and 6 sales selling 34,340 shares for an estimated $3,642,154.
- MARC STAPLEY has made 0 purchases and 5 sales selling 15,000 shares for an estimated $1,915,576.
- AIMEE S WEISNER has made 0 purchases and 4 sales selling 15,000 shares for an estimated $1,760,761.
- GILBERT H KLIMAN sold 5,000 shares for an estimated $536,350
- ALEX R. THURMAN (SVP & CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 4,972 shares for an estimated $522,434.
- TOMAS NAVRATIL (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 7 sales selling 3,124 shares for an estimated $347,253.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GKOS Stock Government Contracts
We have seen $414,356 of award payments to $GKOS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROS IMPLANT: $42,621
- PROS IMPLANT: $42,621
- PROSTHETICS. SURGICAL IMPLANT: $21,340
- LEFT EYE IDOSE ISENT: $21,340
- RIGHT EYE IDOSE ISENT: $21,340
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$GKOS Stock Hedge Fund Activity
We have seen 173 institutional investors add shares of $GKOS Stock stock to their portfolio, and 158 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 3,093,846 shares (-86.4%) from their portfolio in Q4 2025, for an estimated $349,326,151
- JANUS HENDERSON GROUP PLC added 1,953,578 shares (+183.4%) to their portfolio in Q4 2025, for an estimated $220,578,491
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,231,641 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $139,064,585
- PRIMECAP MANAGEMENT CO/CA/ added 1,123,140 shares (+49.8%) to their portfolio in Q4 2025, for an estimated $126,813,737
- HOLOCENE ADVISORS, LP added 752,242 shares (+137.5%) to their portfolio in Q4 2025, for an estimated $84,935,644
- MILLENNIUM MANAGEMENT LLC added 696,289 shares (+76.2%) to their portfolio in Q4 2025, for an estimated $78,617,990
- UBS GROUP AG added 663,849 shares (+316.0%) to their portfolio in Q4 2025, for an estimated $74,955,190
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GKOS Stock Analyst Ratings
Wall Street analysts have issued reports on $GKOS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/18/2026
- Truist Securities issued a "Buy" rating on 12/18/2025
- Needham issued a "Buy" rating on 12/09/2025
- Wells Fargo issued a "Overweight" rating on 10/30/2025
- Citigroup issued a "Buy" rating on 10/30/2025
- JP Morgan issued a "Overweight" rating on 10/30/2025
To track analyst ratings and price targets for $GKOS Stock, check out Quiver Quantitative's $GKOS forecast page.
$GKOS Stock Price Targets
Multiple analysts have issued price targets for $GKOS recently. We have seen 9 analysts offer price targets for $GKOS in the last 6 months, with a median target of $135.0.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $131.0 on 02/18/2026
- David Saxon from Needham set a target price of $127.0 on 02/18/2026
- Larry Biegelsen from Wells Fargo set a target price of $135.0 on 02/18/2026
- Thomas Stephan from Stifel set a target price of $160.0 on 01/22/2026
- George Sellers from Stephens & Co. set a target price of $145.0 on 01/02/2026
- Danielle Antalffy from UBS set a target price of $145.0 on 12/23/2025
- Richard Newitter from Truist Securities set a target price of $145.0 on 12/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
